Eur Rev Med Pharmacol Sci 2018; 22 (16): 5194-5199
DOI: 10.26355/eurrev_201808_15716

Investigation of PD-1H in DEN-induced mouse liver cancer model

C.-J. Lei, B. Wang, Z.-X. Long, H. Ren, Q.-Y. Pan, Y. Li

Department of Tumor Surgery, First Affiliated Hospital of Xi’an Jiaotong University, Xian, Shanxi, China. hongreneij@sohu.com


OBJECTIVE: Immune therapy has recently become a novel strategy for treating liver cancer, making it of critical importance to identify novel targets for treatment. Programmed death-1 homology (PD-1H) is one newly discovered negative co-stimulating molecule, and plays important regulatory roles in suppressing T cell activation. However, the expression or function of PD-1H in liver tumors has not been reported.

MATERIALS AND METHODS: Liver cancer tissues were collected from The Cancer Genome Atlas (TCGA) (http://tcga-data.nci-nih.gov). This study then utilized diethylnitrosamine (DEN) induced liver cancer mice, on which PD-1H monoclonal antibody and PD-1H extra-cellular Fc domain fusion protein were injected intraperitoneal. General status, gross morphology of liver tissues was examined, followed by hematoxylin-eosin (HE) staining and plotting survival curve.

RESULTS: Among TCGA samples, PD-1H expression was significantly elevated. Induced liver cancer mice showed depressed mental status, early onset of hepatitis and liver cirrhosis. Five mice dead in model group (mortality=33.33%). No natural death occurred in control group. Injection of PD-1H-Fc-Ig fusion and PD-1H monoclonal antibody improved the condition to certain extents, with morality at about 20%. Comparing to DEN group, combined treatment group showed significantly fewer tumor lesion on liver surface, with increased body weight and lower liver-body weight ratio. HE staining showed significantly elevated ratio of normal cells in combined treatment group, although large amounts of cancer cells still existed.

CONCLUSIONS: Blocking of PD-1H signal pathway could suppress liver cancer cell growth, decrease mouse mortality, indicating promising application of PD-1H in tumor immune therapy.

Free PDF Download

To cite this article

C.-J. Lei, B. Wang, Z.-X. Long, H. Ren, Q.-Y. Pan, Y. Li
Investigation of PD-1H in DEN-induced mouse liver cancer model

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 16
Pages: 5194-5199
DOI: 10.26355/eurrev_201808_15716